These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23746058)

  • 1. Novel anticancer agents and targets: recent advances and future perspectives.
    Barot KP; Nikolova S; Ivanov I; Ghate MD
    Mini Rev Med Chem; 2013 Jul; 13(9):1239-55. PubMed ID: 23746058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From the sea to anticancer therapy.
    Russo P; Nastrucci C; Cesario A
    Curr Med Chem; 2011; 18(23):3551-62. PubMed ID: 21756228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenome-derived drugs: recent advances and future perspectives.
    Vogiatzi P; Aimola P; Scarano MI; Claudio PP
    Drug News Perspect; 2007 Dec; 20(10):627-33. PubMed ID: 18301797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and Development of Topoisomerase Inhibitors as Anticancer Agents.
    Kathiravan MK; Kale AN; Nilewar S
    Mini Rev Med Chem; 2016; 16(15):1219-1229. PubMed ID: 27549098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazole in the targeted anticancer drug discovery.
    Ayati A; Emami S; Moghimi S; Foroumadi A
    Future Med Chem; 2019 Aug; 11(15):1929-1952. PubMed ID: 31313595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macromolecular Drug Targets in Cancer Treatment and Thiosemicarbazides as Anticancer Agents.
    Küçükgüzel ŞG; Coşkun GP
    Anticancer Agents Med Chem; 2016; 16(10):1288-300. PubMed ID: 26899188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Targets of Active Anticancer Compounds Derived from Marine Sources.
    Song X; Xiong Y; Qi X; Tang W; Dai J; Gu Q; Li J
    Mar Drugs; 2018 May; 16(5):. PubMed ID: 29786660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DHFR Inhibitors: Reading the Past for Discovering Novel Anticancer Agents.
    Raimondi MV; Randazzo O; La Franca M; Barone G; Vignoni E; Rossi D; Collina S
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30909399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterocyclic Scaffolds: Centrality in Anticancer Drug Development.
    Ali I; Lone MN; Al-Othman ZA; Al-Warthan A; Sanagi MM
    Curr Drug Targets; 2015; 16(7):711-34. PubMed ID: 25751009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New regulatory framework for cancer drug development.
    Jones PS; Jones D
    Drug Discov Today; 2012 Mar; 17(5-6):227-31. PubMed ID: 22207222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategy for the development of novel anticancer drugs.
    Saijo N; Tamura T; Nishio K
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S97-101. PubMed ID: 12856152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the exploration of anticancer targets and strategies in enhancing the efficacy of drug targeting.
    Zhu F; Zheng CJ; Han LY; Xie B; Jia J; Liu X; Tammi MT; Yang SY; Wei YQ; Chen YZ
    Curr Mol Pharmacol; 2008 Nov; 1(3):213-32. PubMed ID: 20021435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncology drug discovery: planning a turnaround.
    Toniatti C; Jones P; Graham H; Pagliara B; Draetta G
    Cancer Discov; 2014 Apr; 4(4):397-404. PubMed ID: 24706659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application.
    Seca AML; Pinto DCGA
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29337925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 0 trials for anticancer drug development.
    Nat Rev Drug Discov; 2009 Jun; 8(6):442. PubMed ID: 19483703
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticancer drug discovery in the future: an evolutionary perspective.
    Ma X; Wang Z
    Drug Discov Today; 2009 Dec; 14(23-24):1136-42. PubMed ID: 19800414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the development of hybrid anticancer drugs.
    Fortin S; Bérubé G
    Expert Opin Drug Discov; 2013 Aug; 8(8):1029-47. PubMed ID: 23646979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Future directions of anticancer drug development in Japan].
    Akaza H; Kawai K; Tsuruo T; Tsukagoshi S; Aiba K; Shimada Y; Kakeji Y; Ishikawa H; Ikeda T; Nakamura S; Tamura T; Yamamoto N; Isonishi S; Hinotsu S; Hirose M; Katsura J
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):351-60. PubMed ID: 18281781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New cast for a new era: preclinical cancer drug development revisited.
    Herter-Sprie GS; Kung AL; Wong KK
    J Clin Invest; 2013 Sep; 123(9):3639-45. PubMed ID: 23999436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-target compounds acting in cancer progression: Focus on thiosemicarbazone, thiazole and thiazolidinone analogues.
    de Siqueira LRP; de Moraes Gomes PAT; de Lima Ferreira LP; de Melo Rêgo MJB; Leite ACL
    Eur J Med Chem; 2019 May; 170():237-260. PubMed ID: 30904782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.